Risk scores for predicting death in COPD patients

Michal Svoboda (Znojmo, Czech Republic), Michal Svoboda, Jan Svancara, Jiri Jarkovsky, Barbora Novotna, Patrice Popelkova, Marek Plutinsky, Kristian Brat, Jaromir Zatloukal, Eva Volakova, Karel Hejduk, Eva Kocova, Michal Kopecky, Katerina Neumannova, Miroslava Fecaninova, Petr Safranek, Tomas Dvorak, Ondrej Sobotik, Zuzana Liptakova, Lucie Heribanova, Blanka Snelerova, Marie Majerciakova, Pavlina Musilova, Vladimir Koblizek

Source: International Congress 2016 – Highlights in the management of COPD and beyond
Session: Highlights in the management of COPD and beyond
Session type: Oral Presentation
Number: 1508
Disease area: Airway diseases

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Michal Svoboda (Znojmo, Czech Republic), Michal Svoboda, Jan Svancara, Jiri Jarkovsky, Barbora Novotna, Patrice Popelkova, Marek Plutinsky, Kristian Brat, Jaromir Zatloukal, Eva Volakova, Karel Hejduk, Eva Kocova, Michal Kopecky, Katerina Neumannova, Miroslava Fecaninova, Petr Safranek, Tomas Dvorak, Ondrej Sobotik, Zuzana Liptakova, Lucie Heribanova, Blanka Snelerova, Marie Majerciakova, Pavlina Musilova, Vladimir Koblizek. Risk scores for predicting death in COPD patients. Eur Respir J 2016; 48: Suppl. 60, 1508

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Risk factors for new-onset asthma and early COPD in a cohort of young adults
Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD
Year: 2015

The characteristics of ACOS in a population based asthma cohort
Source: International Congress 2016 – COPD and asthma COPD overlap syndrome (ACOS): novelties in terms of prevalence, risk factors, and prognosis in COPD
Year: 2016


Relationship of baseline or annual change of clinical parameters on mortality in patients with COPD
Source: Annual Congress 2013 –Risk factors for COPD and lung function decline
Year: 2013

4–year trajectory of medication adherence amongst severe asthma patients: Risk factors and impact on asthma control
Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma
Year: 2016


COPD-specific co-morbidity test (COTE) for predicting mortality in COPD – Results of an European, multicenter study
Source: International Congress 2014 – Markers
Year: 2014

Predictors of accelerated decline in FEV1 in a prospective new-onset asthma cohort
Source: International Congress 2016 – Phenotyping asthma
Year: 2016


Cardiovascular status of patients with a severe form of COPD
Source: International Congress 2015 – Diagnosing and management of COPD in primary care
Year: 2015


COPD and risk of cardiovascular disease: A prospective study of 0.5M Chinese adults
Source: International Congress 2015 – COPD and lung function: risk factors and outcomes
Year: 2015

The bronchitic phenotype is related to morbidity and mortality - report from the OLIN COPD study
Source: Annual Congress 2013 –Investigating COPD in longitudinal studies
Year: 2013

Modifiable risk factors for all-cause hospitalization in obstructive lung disease
Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD
Year: 2015

Measuring exacerbations in subjects with mild to moderate COPD from a population-based cohort: The CanCOLD study
Source: Annual Congress 2013 –Factors associated with outcomes in COPD
Year: 2013


Stable state MR-proadrenomedullin level in COPD patients; a validation study
Source: International Congress 2014 – Comorbidities
Year: 2014


Cardiovascular risk assessment in COPD patients with severe exacerbation
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016


Change in the COPD assessment test (CAT) score as predictor of short-term evolution of patients admitted for an exacerbation of COPD
Source: International Congress 2014 – COPD: points to ponder
Year: 2014

Characteristics of subjects susceptible to exacerbation-like respiratory events in a population-based cohort: Canadian cohort obstructive lung disease (CanCOLD) study
Source: International Congress 2014 – Longitudinal studies of respiratory disease
Year: 2014


Differences in the disease phenotype and comorbidities between patients with COPD and alpha-1-antitrypsin deficiency - An analysis of the COSYCONET cohort
Source: International Congress 2016 – Prevalence, prognosis, and risk factors of COPD
Year: 2016

Risk factors for another hospitalization in COPD patients hospitalized for exacerbation
Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases
Year: 2016


Distribution and significance of GOLD 2011 disease severity classification in patients with COPD in China: A national cross-sectional survey
Source: Annual Congress 2013 –COPD: acute exacerbations and others
Year: 2013

Prognostic assessment in chronic obstructive pulmonary disease using copeptin: A simplified risk index
Source: International Congress 2015 – Monitoring and phenotyping COPD
Year: 2015


Risk factors of re-hospitalisation for a COPD exacerbation: a prospective study
Source: Eur Respir J 2002; 20: Suppl. 38, 402s
Year: 2002